Pareto Biotechnologies is a synthetic biology startup that is poised to lead the movement towards a bio-based economy. Pareto's platform fully leverages its dominant IP position in polyketide pathways, combining structurally-guided enzyme design and synthetic biology to develop a platform for designer molecules with universal applicability. In the near term, Pareto's focus is on developing novel molecules for the cosmetics, flavors, and fragrances industries by 2015. Longer term, Pareto will create molecules that can be used in nutraceuticals, pharmaceuticals, and industrial commodities, such as plastics, resins, and adhesives.
